Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Corcept Therapeutics Inc (NASDAQ:CORT)

9.54
Delayed Data
As of Apr 28
 +0.20 / +2.14%
Today’s Change
4.60
Today|||52-Week Range
11.58
+31.40%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Revenue and IncomeNet Revenues16.1M19.7M21.7M23.8M
 
 
 
 
 
Cost of Goods Sold376.0K402.0K647.0K546.0K
 
 
 
 
 
Depreciation And Amortization27.0K24.0K21.0K15.0K
 
 
 
 
 
 
Operating ExpensesGross Income15.7M19.3M21.1M23.3M
 
 
 
 
 
General Expenses15.1M17.8M18.0M18.2M
 
 
 
 
 
Research And Development4.6M5.7M7.1M6.5M
 
 
 
 
 
Total Operating Expenses15.5M18.2M18.7M18.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income592.0K1.5M3.1M5.0M
 
 
 
 
 
Interest Expense On Debt584.0K523.0K455.0K367.0K
 
 
 
 
 
Other Expenses-27.0K-8.0K-32.0K-42.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-19.0K977.0K2.6M4.6M
 
 
 
 
 
Net Income-19.0K977.0K2.6M4.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS109.7M110.0M110.7M111.9M
 
 
 
 
 
Shares To Calculate EPS Diluted109.7M115.3M116.4M118.9M
 
 
 
 
 
 
Earnings Per ShareEPS$0.00$0.01$0.02$0.04
 
 
 
 
EPS Diluted-$0.00$0.01$0.02$0.04